搜尋





搜尋





Biodexa Pharmaceuticals PLC

BDRX

添加自選

0.681USD

+0.001+0.15%

收盤 09-22 16:00（美東）

700.82K總市值

3.88本益比TTM

盤前交易 08:24 (美東)0.680USD-0.001-0.15%

Biodexa Pharmaceuticals PLC

0.681

+0.001+0.15%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

BDRX 利潤表

您可以在這裡找到Biodexa Pharmaceuticals PLC的年度或季度收入報告，以深入了解Biodexa Pharmaceuticals PLC的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2025H2

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

FY2015H2

FY2015H1

FY2014H2

FY2014H1

FY2013H2

FY2013H1

營業總收入

----

-100.00%0.00

-63.11%67.09K

-41.49%237.39K

29.19%181.89K

39.04%405.72K

11.13%140.79K

122.38%291.81K

-30.44%126.68K

-64.33%131.22K

-83.08%182.13K

-12.35%367.87K

190.87%1.08M

19.26%419.72K

-85.24%370.18K

-87.70%351.93K

240.63%2.51M

1262.44%2.86M

810.34%736.36K

813.19%210.06K

3064.73%80.89K

-74.83%23.00K

--2.56K

--91.37K

營業收入

----

-100.00%0.00

-63.11%67.09K

-41.49%237.39K

29.19%181.89K

39.04%405.72K

11.13%140.79K

122.38%291.81K

-30.44%126.68K

-64.33%131.22K

-83.08%182.13K

-12.35%367.87K

190.87%1.08M

19.26%419.72K

-85.24%370.18K

-87.70%351.93K

240.63%2.51M

1262.44%2.86M

810.34%736.36K

813.19%210.06K

37.60%80.89K

-34.55%23.00K

--58.79K

--35.14K

主營業務成本

----

-698.31%-293.43K

--776.64K

--49.04K

----

營業費用

----

22.15%3.80M

-13.00%3.15M

-26.55%3.11M

-1.70%3.62M

35.26%4.24M

39.16%3.68M

5.82%3.13M

-51.07%2.65M

-42.65%2.96M

16.63%5.41M

-3.90%5.17M

-11.08%4.64M

32.40%5.38M

-1.40%5.21M

-57.77%4.06M

-50.31%5.29M

57.66%9.61M

193.57%10.64M

35.69%6.10M

81.68%3.62M

580.13%4.49M

-13.57%1.99M

--660.70K

--2.31M

研發費用

----

69.16%2.48M

-9.00%1.63M

-30.90%1.47M

-14.28%1.79M

1.01%2.12M

43.02%2.09M

39.74%2.10M

-53.05%1.46M

-58.16%1.50M

10.67%3.12M

-2.61%3.60M

-19.86%2.82M

23.80%3.69M

13.20%3.51M

-19.96%2.98M

101.36%3.10M

29.81%3.73M

30.47%1.54M

2.77%2.87M

46.72%1.18M

824.32%2.79M

-13.22%805.11K

--302.24K

--927.80K

折舊攤銷及損耗

----

-20.28%90.21K

-11.01%101.38K

-9.04%113.17K

-27.80%113.92K

-30.18%124.41K

21.13%157.78K

-61.78%178.17K

-70.90%130.26K

-11.35%466.19K

-14.61%447.55K

29.96%525.88K

-26.12%524.13K

-55.97%404.65K

-25.45%709.48K

-48.13%919.00K

-41.21%951.64K

363.18%1.77M

1207.21%1.62M

164.93%382.54K

82.83%123.83K

270.46%144.39K

-43.01%67.73K

--38.98K

--118.85K

其他營業費用

----

-109.43%-23.70K

----

-139.54%-11.32K

100.00%0.00

-184.85%-4.72K

38.51%-13.87K

164.10%5.57K

---22.56K

29.41%-8.69K

----

---12.31K

----

營業利潤

----

-24.83%-3.80M

6.89%-3.15M

24.91%-3.05M

-3.22%-3.38M

-35.55%-4.06M

-39.17%-3.28M

-5.59%-2.99M

55.39%-2.35M

43.10%-2.84M

-23.60%-5.28M

-15.93%-4.98M

10.97%-4.27M

-16.50%-4.30M

2.87%-4.79M

48.07%-3.69M

36.55%-4.94M

-32.53%-7.11M

-127.81%-7.78M

-21.49%-5.36M

-73.14%-3.41M

-570.48%-4.41M

11.04%-1.97M

---658.15K

---2.22M

淨非營業利息收入（費用）

利息收入

----

54.42%61.16K

235.31%64.11K

118.71%39.61K

267.56%19.12K

--18.11K

--5.20K

-100.00%0.00

-98.38%6.52K

-4.03%781.07

51864.07%402.82K

6.45%813.87

-99.73%775.19

-92.66%764.53

-37.44%287.68K

-98.19%10.42K

-60.53%459.84K

3071.33%575.71K

28948.81%1.17M

1320.51%18.15K

-98.54%4.01K

--1.28K

--275.40K

----

利息費用

----

-50.22%7.65K

-53.21%8.20K

-32.74%15.36K

-15.77%17.53K

24.82%22.83K

29.96%20.81K

2427.22%18.29K

-6.83%16.01K

-99.16%723.90

31.96%17.18K

-67.98%86.14K

-92.90%13.02K

681.14%268.99K

304.27%183.49K

-41.32%34.44K

--45.39K

--58.69K

----

-86.47%7.78K

-80.71%47.46K

--57.51K

--246.01K

----

出售證券收益

----

-1112.00%-81.80K

---26.84K

--8.08K

----

100.26%795.42

----

-2399.67%-301.87K

----

--13.13K

--6.51K

----

--4.90K

----

---274.76K

特殊收入（費用）

----

2210.17%1.89M

82.06%559.82K

48.12%81.64K

-10.88%307.50K

-93.52%55.12K

453.84%345.04K

191.49%851.10K

98.87%-97.51K

---930.22K

---8.66M

--0.00

----

100.00%0.00

----

88.27%-1.08M

----

---9.18M

----

-固定資產出售收益

----

89.16%3.06K

----

-82.89%1.62K

-100.00%0.00

114.14%9.45K

-94.33%1.73K

---66.82K

--30.56K

----

其他非經營性收入（費用）

----

-89.16%-3.06K

----

82.89%-1.62K

100.00%0.00

-114.14%-9.45K

94.33%-1.73K

--66.82K

---30.56K

----

稅前利潤

----

33.65%-1.95M

16.69%-2.56M

26.81%-2.93M

-4.28%-3.07M

-85.52%-4.01M

-19.41%-2.95M

46.81%-2.16M

82.32%-2.47M

12.71%-4.06M

-226.40%-13.95M

-1.90%-4.65M

14.12%-4.27M

-1.20%-4.57M

-0.12%-4.98M

71.58%-4.51M

30.99%-4.97M

-278.87%-15.88M

-111.59%-7.20M

5.95%-4.19M

-67.83%-3.40M

-608.73%-4.46M

18.59%-2.03M

---628.75K

---2.49M

所得稅

----

-0.19%-95.57K

59.39%-93.18K

75.53%-95.38K

21.47%-229.43K

-19.51%-389.76K

-70.12%-292.15K

46.50%-326.12K

49.91%-171.74K

22.04%-609.53K

49.36%-342.89K

11.76%-781.85K

0.37%-677.14K

-98.88%-886.05K

-41.84%-679.66K

92.89%-445.51K

53.35%-479.17K

-1051.13%-6.27M

-345.06%-1.03M

-26.84%-544.38K

3.93%-230.81K

-104.77%-429.17K

20.17%-240.26K

---209.58K

---300.96K

除稅後利潤

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

10.83%-3.45M

-278.32%-13.61M

-5.19%-3.87M

16.30%-3.60M

9.50%-3.68M

4.33%-4.30M

57.69%-4.07M

27.27%-4.49M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

持續經營利潤

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

10.83%-3.45M

-278.32%-13.61M

-5.19%-3.87M

16.30%-3.60M

9.50%-3.68M

4.33%-4.30M

57.69%-4.07M

27.27%-4.49M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

停止經營利潤

----

--0.00

----

100.00%0.00

----

-188.62%-776.93K

100.00%0.00

189.79%876.74K

-98.55%-4.43M

---976.40K

---2.23M

----

歸属于母公司的淨利潤

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

25.73%-3.45M

-278.32%-13.61M

-65.79%-4.65M

58.78%-3.60M

44.41%-2.80M

-29.81%-8.73M

47.53%-5.04M

-8.86%-6.72M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

歸屬普通股東的淨利潤

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

25.73%-3.45M

-278.32%-13.61M

-65.79%-4.65M

58.78%-3.60M

44.41%-2.80M

-29.81%-8.73M

47.53%-5.04M

-8.86%-6.72M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

基本每股收益

99.44%0.00

96.85%0.00

100.00%0.00

99.98%-0.01

-8438.71%-46.01

-15457.63%-58.36

25.69%-0.54

68.28%-0.38

92.73%-0.73

72.56%-1.18

-736.52%-9.97

90.60%-4.31

99.17%-1.19

50.98%-45.84

-3.49%-142.84

62.38%-93.51

25.18%-138.03

-95.32%-248.54

-61.64%-184.49

65.44%-127.25

54.57%-114.13

-2341.66%-368.20

-218.83%-251.25

---15.08

---78.81

稀釋每股收益

99.44%0.00

96.85%0.00

100.00%0.00

99.98%-0.01

-8438.71%-46.01

-15457.63%-58.36

25.69%-0.54

68.28%-0.38

92.73%-0.73

72.56%-1.18

-736.52%-9.97

90.60%-4.31

99.17%-1.19

50.98%-45.84

-3.49%-142.84

62.38%-93.51

25.18%-138.03

-95.32%-248.54

-61.64%-184.49

65.44%-127.25

54.57%-114.13

-2341.66%-368.20

-218.83%-251.25

---15.08

---78.81

每股派息

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Biodexa Pharmaceuticals PLC 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 BDRX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Biodexa Pharmaceuticals PLC 全年的淨利潤是多少？



Biodexa Pharmaceuticals PLC 2025 財年淨利潤為 -4.82M。

Biodexa Pharmaceuticals PLC 年度營業利潤是多少？



Biodexa Pharmaceuticals PLC 2025 財年的營業利潤為 -11.46M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。